SCHEMBL6154229

SCHEMBL6154229

FC(F)(F)c1cccc(Oc2c[c]cc(Oc3cccc(C(F)(F)F)c3)c2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TEAD1 P28347 1/20 0.48
LTA4H P09960 1/20 0.46
KIF11 P52732 1/20 0.46
L3MBTL1 Q9Y468 4/20 0.44
POLB P06746 2/20 0.44
ALDH1A1 P00352 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
MAPT P10636 2/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
ABCG2 Q9UNQ0 1/20 0.43
ADORA2A P29274 1/20 0.42
SCN9A Q15858 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
KDM4E B2RXH2 2/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6155481 0.89 TEAD1 (0.43) TEAD1LTA4HKIF11L3MBTL1POLB
SCHEMBL9798371 0.87 LTA4H (0.54) TEAD1LTA4HKIF11L3MBTL1POLB
SCHEMBL919095 0.86 TEAD1 (0.46) TEAD1LTA4HKIF11L3MBTL1POLB
SCHEMBL27579381 0.83 LTA4H (0.59) TEAD1LTA4HKIF11L3MBTL1POLB
SCHEMBL694092 0.82 LTA4H (0.49) TEAD1LTA4HKIF11L3MBTL1POLB
SCHEMBL20526142 0.82 LTA4H (0.43) TEAD1LTA4HL3MBTL1ALDH1A1NPSR1
SCHEMBL9546526 0.81 L3MBTL1 (0.55) TEAD1LTA4HKIF11L3MBTL1POLB
SCHEMBL13791556 0.80 L3MBTL1 (0.65) TEAD1LTA4HKIF11L3MBTL1POLB
SCHEMBL9589388 0.79 RAB9A (0.55) TEAD1LTA4HKIF11L3MBTL1POLB
SCHEMBL7077333 0.78 POLB (0.50) TEAD1LTA4HKIF11L3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP TEAD1 1649/4885LTA4H 2659/4885KIF11 3849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.